2013 ACCF/ACR/ASE/ASNC/SCCT/SCMR appropriate utilization of cardiovascular imaging in heart failure: A joint report of the American college of radiology appropriateness criteria committee and the American college of cardiology foundation appropriate use criteria task force

Journal of the American College of Cardiology

Volumn 61, Issue 21, 2013, Pages 2207-2231

  Patel, Manesh R ^a   White, Richard D ^b   Abbara, Suhny ^b   Bluemke, David A ^b   Herfkens, Robert J ^b   Picard, Michael ^a   Shaw, Leslee J ^a   Silver, Marc ^a   Stillman, Arthur E ^b   Udelson, James ^a   Alagona, Peter ^a   Aurigemma, Gerard ^c   Butler, Javed ^d   Casey, Don ^e   Cury, Ricardo ^f   Flamm, Scott ^g   Gardner, Tim ^h   Krishnamurthy, Rajesh ⁱ   Messer, Joseph ^a   Rich, Michael W ^j   Royal, Henry ^k   Smetana, Gerald ^e   Tilkemeier, Peter ^l   Walsh, Mary Norine ^d   Woodard, Pamela K ^b   Felker, G Michael ^d   Ferrari, Victor ^e   Gerson, Myron ^l   Givertz, Michael M ^d   Goldstein, Daniel J ^m   Jacobs, Jill E ^h   Janowitz, Warren R ⁱ   Jerome, Scott ⁿ   Lesser, John ^f   McConnell, Michael ^g   Nagueh, Sherif F ⁿ   Ordovas, Karen G ^o   Soman, Prem ^l   Spencer, Kirk ^c   Stainback, Raymond F ^a   Vijayaraghavan, Krishnaswami ^p   Tang, W H Wilson ^d   more..

^a AMERICAN COLLEGE OF CARDIOLOGY   (United States)

^b American College of Radiology Representative   (United States)

^c AMERICAN SOCIETY OF ECHOCARDIOGRAPHY   (United States)

^d Heart Failure Society of America Representative   (United States)

^e AMERICAN COLLEGE OF PHYSICIANS   (United States)

^f Society of Cardiovascular Computed Tomography Representative   (United States)

^g Society for Cardiovascular Magnetic Resonance Representative   (United States)

^h AMERICAN HEART ASSOCIATION   (United States)

ⁱ Radiological Society of North America Representative   (United States)

^j American Geriatrics Society Representative   (United States)

^k Society of Nuclear Medicine   (United States)

^l American Society of Nuclear Cardiology Representative   (United States)

^m Society of Thoracic Surgeons Representative   (United States)

ⁿ Intersocietal Accreditation Commission Representative   (United States)

^o North American Society for Cardiovascular Imaging Representative   (United States)

^p American College of Chest Physicians Representative   (United States)

more..

Author keywords

ACCF Appropriate Use Criteria; appropriate utilization; appropriateness criteria; heart failure; imaging; multimodality

Indexed keywords

CARVEDILOL; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; PLACEBO;

ANGINA PECTORIS; ANGIOCARDIOGRAPHY; CARDIAC IMAGING; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MAGNETIC RESONANCE; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; FOLLOW UP; HEART CATHETERIZATION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC HEART DISEASE; MYOCARDIAL HIBERNATION; MYOCARDIAL PERFUSION IMAGING; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REPEAT PROCEDURE; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SUDDEN DEATH;

EID: 84877996130     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.02.005     Document Type: Article

References (144)

1. J.J. Carr, R.C. Hendel, R.D. White 2013 Appropriate utilization of cardiovascular imaging: a methodology for the development of joint criteria for the appropriate utilization of cardiovascular imaging by the American College of Cardiology Foundation and American College of Radiology J Am Coll Cardiol 2013 10.1016/j.jacc.2013.02.010 April 23 [E-pub ahead of print]
2. W.H. Barker, J.P. Mullooly, W. Getchell Changing incidence and survival for heart failure in a well-defined older population, 1970-1974 and 1990-1994 Circulation 113 2006 799 805
3. L.R. Loehr, W.D. Rosamond, P.P. Chang Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study) Am J Cardiol 101 2008 1016 1022
4. W.B. Kannel, A.J. Belanger Epidemiology of heart failure Am Heart J 121 1991 951 957
5. K.A. Fox, P.G. Steg, K.A. Eagle Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006 JAMA 297 2007 1892 1900
6. F.A. Masoudi, E.P. Havranek, H.M. Krumholz The burden of chronic congestive heart failure in older persons: magnitude and implications for policy and research Heart Fail Rev 7 2002 9 16
7. D. Lloyd-Jones, R.J. Adams, T.M. Brown Heart disease and stroke statistics - 2010 update: a report from the American Heart Association Circulation 121 2010 e46 e215
8. U.S. Government Accountability Office Medicare Part B Imaging Services: Rapid Spending Growth and Shift to Physician Offices Indicate Need for CMS to Consider Additional Management Practices. GAO Report GAO-08-452 2008 http://www.gao.gov/assets/280/276735.pdf Accessed January 2010
9. L.J. Shaw, J.K. Min, R. Hachamovitch Cardiovascular imaging research at the crossroads J Am Coll Cardiol Img 3 2010 316 324
10. S.A. Hunt, W.T. Abraham, M.H. Chin 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 53 2009 e1 e90
11. K. Fitch, S.J. Bernstein, M.D. Aguilar The RAND/UCLA Appropriateness Method User's Manual 2001 RAND Santa Monica, CA
12. American College of Radiology Overview for the Diagnostic Modality Accreditation Program Revised April 2012 http://www.acr.org/∼/media/ACR/ Documents/Accreditation/Apply/DiagnosticReqs.pdf Accessed September 1, 2010
13. AQA Principles for Appropriateness Criteria Performance Measurement Workgroup June 2009 http://www.aqaalliance.org/files/ AppropriatenessCriteriaPrinciples.pdf Accessed September 1, 2010
14. AQA Parameters for Selecting Measures for Physician and Other Clinician Performance Performance Measurement Workgroup. AQA Alliance June 2009 http://www.aqaalliance.org/files/AQAParametersforSelectingAmbulatoryCare.pdf Accessed September 1, 2010
15. ICACTL Standards for Computed Tomography (CT) Laboratory Operations http://www.intersocietal.org/ct/ Accessed September 1, 2010
16. ICAMRL Standards for Accreditation in Magnetic Resonance Imaging Operations http://www.intersocietal.org/mri/ Accessed September 1, 2010
17. ICANL Standards for Nuclear Cardiology, Nuclear Medicine and PET Accreditation http://www.intersocietal.org/nuclear/ Accessed September 1, 2010
18. ICAEL Standards for Accreditation in Adult Echocardiography Testing http://www.intersocietal.org/echo/ Accessed September 1, 2010
19. G.S. Francis, G.L. Pierpont Pathophysiology of congestive heart failure secondary to congestive and ischemic cardiomyopathy Cardiovasc Clin 19 1988 57 74
20. S.M. Stevens, R. Farzaneh-Far, B. Na Development of an echocardiographic risk-stratification index to predict heart failure in patients with stable coronary artery disease: the Heart and Soul study J Am Coll Cardiol Img 2 2009 11 20
21. D.W. Kitzman, J.M. Gardin, J.S. Gottdiener Cardiovascular Health Study Research Group Importance of heart failure with preserved systolic function in patients > or = 65 years of age Am J Cardiol 87 2001 413 419
22. F.A. Masoudi, E.P. Havranek, G. Smith Gender, age, and heart failure with preserved left ventricular systolic function J Am Coll Cardiol 41 2003 217 223
23. C. Fonseca, H. Morais, T. Mota The diagnosis of heart failure in primary care: value of symptoms and signs Eur J Heart Fail 6 2004 795-2
24. A.M. Keogh, D.W. Baron, J.B. Hickie Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation Am J Cardiol 65 1990 903 908
25. M.A. Quinones, B.H. Greenberg, H.A. Kopelen SOLVD Investigators Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy J Am Coll Cardiol 35 2000 1237 1244
26. J.P. Curtis, S.I. Sokol, Y. Wang The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure J Am Coll Cardiol 42 2003 736 742
27. S.D. Solomon, N. Anavekar, H. Skali Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients Circulation 112 2005 3738 3744
28. Deleted in proof.
29. J.M. Gardin, R. McClelland, D. Kitzman M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study) Am J Cardiol 87 2001 1051 1057
30. G.P. Aurigemma, J.S. Gottdiener, L. Shemanski Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the cardiovascular health study J Am Coll Cardiol 37 2001 1042 1048
31. T.K. Lim, H. Ashrafian, G. Dwivedi Increased left atrial volume index is an independent predictor of raised serum natriuretic peptide in patients with suspected heart failure but normal left ventricular ejection fraction: implication for diagnosis of diastolic heart failure Eur J Heart Fail 8 2006 38 45
32. A.A. Chen, M.J. Wood, D.G. Krauser NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy Eur Heart J 27 2006 839 845
33. P.A. Grayburn, C.P. Appleton, A.N. DeMaria Echocardiographic predictors of morbidity and mortality in patients with advanced heart failure: the Beta-blocker Evaluation of Survival Trial (BEST) J Am Coll Cardiol 45 2005 1064 1071
34. C.M. Francis, L. Caruana, P. Kearney Open access echocardiography in management of heart failure in the community BMJ 310 1995 634 636
35. G.A. Whalley, S.P. Wright, A. Pearl Prognostic role of echocardiography and brain natriuretic peptide in symptomatic breathless patients in the community Eur Heart J 29 2008 509 516
36. V. Melenovsky, B.A. Borlaug, B. Rosen Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction J Am Coll Cardiol 49 2007 198 207
37. H. Persson, E. Lonn, M. Edner Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence: results from the CHARM Echocardiographic Substudy-CHARMES J Am Coll Cardiol 49 2007 687 694
38. B.R. Davis, J.B. Kostis, L.M. Simpson Heart failure with preserved and reduced left ventricular ejection fraction in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Circulation 118 2008 2259 2267
39. S.M. St John, M.A. Pfeffer, L. Moye Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial Circulation 96 1997 3294 3299
40. W.G. Hundley, D.A. Bluemke, J.P. Finn ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents J Am Coll Cardiol 55 2010 2614 2662 10.1016/j.jacc.2009.11.011
41. C. Jenkins, S. Moir, J. Chan Left ventricular volume measurement with echocardiography: a comparison of left ventricular opacification, three-dimensional echocardiography, or both with magnetic resonance imaging Eur Heart J 30 2009 98 106
42. A. Valle-Munoz, J. Estornell-Erill, C.J. Soriano-Navarro Late gadolinium enhancement-cardiovascular magnetic resonance identifies coronary artery disease as the aetiology of left ventricular dysfunction in acute new-onset congestive heart failure Eur J Echocardiogr 10 2009 968 974
43. D.A. Bluemke, R.A. Kronmal, J.A. Lima The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study J Am Coll Cardiol 52 2008 2148 2155
44. J. Bogaert, M. Francone Cardiovascular magnetic resonance in pericardial diseases J Cardiovasc Magn Reson 11 2009 14
45. C.A. Warnes, R.G. Williams, T.M. Bashore ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease) J Am Coll Cardiol 52 2008 e1 e121
46. K.J. Nichols, T.A. Van, Y. Wang Automated detection of left ventricular dyskinesis by gated blood pool SPECT Nucl Med Commun 31 2010 881 888
47. A.E. Atchley, D.W. Kitzman, D.J. Whellan Myocardial perfusion, function, and dyssynchrony in patients with heart failure: baseline results from the single-photon emission computed tomography imaging ancillary study of the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION) trial Am Heart J 158 2009 S53 S63
48. M.A. Konstam, D.G. Kramer, A.R. Patel Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment J Am Coll Cardiol Img 4 2011 98 108
49. N. van Royen, C.C. Jaffe, H.M. Krumholz Comparison and reproducibility of visual echocardiographic and quantitative radionuclide left ventricular ejection fractions Am J Cardiol 77 1996 843 850
50. J.E. Udelson, A.M. Feldman, B. Greenberg Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction Circ Heart Fail 3 2010 347 353
51. E. Vizzardi, A. D'Aloia, R. Giubbini Effect of spironolactone on left ventricular ejection fraction and volumes in patients with class I or II heart failure Am J Cardiol 106 2010 1292 1296
52. V. Rizzello, D. Poldermans, E. Biagini Prognosis of patients with ischaemic cardiomyopathy after coronary revascularisation: relation to viability and improvement in left ventricular ejection fraction Heart 95 2009 1273 1277
53. A. Chander, M. Brenner, R. Lautamaki Comparison of measures of left ventricular function from electrocardiographically gated 82Rb PET with contrast-enhanced CT ventriculography: a hybrid PET/CT analysis J Nucl Med 49 2008 1643 1650
54. D. Baim, W. Grossman Grossman's Cardiac Catheterization, Angiography, and Intervention 7th edition 2005 Lippincott Williams & Wilkins Philadelphia, PA
55. E.M. Antman, M. Hand, P.W. Armstrong 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction J Am Coll Cardiol 51 2008 210 247 10.1016/j.jacc.2007.10.001
56. M. Gheorghiade, R.O. Bonow Chronic heart failure in the United States: a manifestation of coronary artery disease Circulation 97 1998 282 289
57. L.J. Shaw, D.S. Berman, D.J. Maron Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy Circulation 117 2008 1283 1291
58. R. Hachamovitch, S.W. Hayes, J.D. Friedman Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography Circulation 107 2003 2900 2907
59. P.S. Douglas, A. Taylor, D. Bild Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute J Am Coll Cardiol Img 2 2009 897 907
60. A. Abidov, A. Rozanski, R. Hachamovitch Prognostic significance of dyspnea in patients referred for cardiac stress testing N Engl J Med 353 2005 1889 1898
61. E.J. Velazquez, K.L. Lee, C.M. O'Connor The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial J Thorac Cardiovasc Surg 134 2007 1540 1547
62. A. Elhendy, F. Sozzi, R.T. van Domburg Effect of myocardial ischemia during dobutamine stress echocardiography on cardiac mortality in patients with heart failure secondary to ischemic cardiomyopathy Am J Cardiol 96 2005 469 473
63. W. Maskoun, N. Mustafa, J. Mahenthiran Wall motion abnormalities with low-dose dobutamine predict a high risk of cardiac death in medically treated patients with ischemic cardiomyopathy Clin Cardiol 32 2009 403 409
64. F.B. Sozzi, A. Elhendy, V. Rizzello Prognostic significance of akinesis becoming dyskinesis during dobutamine stress echocardiography J Am Soc Echocardiogr 20 2007 257 261
65. E. Dall'Armellina, T.M. Morgan, S. Mandapaka Prediction of cardiac events in patients with reduced left ventricular ejection fraction with dobutamine cardiovascular magnetic resonance assessment of wall motion score index J Am Coll Cardiol 52 2008 279 286
66. M. Yokokawa, H. Tada, T. Toyama Magnetic resonance imaging is superior to cardiac scintigraphy to identify nonresponders to cardiac resynchronization therapy Pacing Clin Electrophysiol 32 Suppl 1 2009 S57 S62
67. R. Krittayaphong, A. Maneesai, V. Chaithiraphan Comparison of diagnostic and prognostic value of different electrocardiographic criteria to delayed-enhancement magnetic resonance imaging for healed myocardial infarction Am J Cardiol 103 2009 464 470
68. Deleted in proof.
69. P. Vaduganathan, Z.X. He, G.W. Vick III Evaluation of left ventricular wall motion, volumes, and ejection fraction by gated myocardial tomography with technetium 99m-labeled tetrofosmin: a comparison with cine magnetic resonance imaging J Nucl Cardiol 6 1999 3 10
70. J.G. Cleland, D.J. Pennell, S.G. Ray Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial Lancet 362 2003 14 21
71. P. Soman, A. Lahiri, J.H. Mieres Etiology and pathophysiology of new-onset heart failure: evaluation by myocardial perfusion imaging J Nucl Cardiol 16 2009 82 91
72. F.T. Range, M. Paul, K.P. Schafers Myocardial perfusion in nonischemic dilated cardiomyopathy with and without atrial fibrillation J Nucl Med 50 2009 390 396
73. M. Feola, A. Biggi, S. Chauvie Myocardial scar and insulin resistance predict cardiovascular events in severe ischaemic myocardial dysfunction: a perfusion-metabolism positron emission tomography study Nucl Med Commun 29 2008 448 454
74. H. Tuunanen, E. Engblom, A. Naum Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure Circulation 114 2006 2130 2137
75. K. Thompson, G. Saab, D. Birnie Is septal glucose metabolism altered in patients with left bundle branch block and ischemic cardiomyopathy? J Nucl Med 47 2006 1763 1768
76. M.J. Budoff, D.M. Shavelle, D.H. Lamont Usefulness of electron beam computed tomography scanning for distinguishing ischemic from nonischemic cardiomyopathy J Am Coll Cardiol 32 1998 1173 1178
77. D. Andreini, G. Pontone, M. Pepi Diagnostic accuracy of multidetector computed tomography coronary angiography in patients with dilated cardiomyopathy J Am Coll Cardiol 49 2007 2044 2050
78. J.C. Cornily, M. Gilard, G. Le Gal Accuracy of 16-detector multislice spiral computed tomography in the initial evaluation of dilated cardiomyopathy Eur J Radiol 61 2007 84 90
79. E.L. Alderman, L.D. Fisher, P. Litwin Results of coronary artery surgery in patients with poor left ventricular function (CASS) Circulation 68 1983 785 795
80. K.F. Fox, M.R. Cowie, D.A. Wood Coronary artery disease as the cause of incident heart failure in the population Eur Heart J 22 2001 228 236
81. S. Arques, P. Ambrosi, R. Gelisse Prevalence of angiographic coronary artery disease in patients hospitalized for acute diastolic heart failure without clinical and electrocardiographic evidence of myocardial ischemia on admission Am J Cardiol 94 2004 133 135
82. S.H. Rahimtoola, G. La Canna, R. Ferrari Hibernating myocardium: another piece of the puzzle falls into place J Am Coll Cardiol 47 2006 978 980
83. K.C. Allman, L.J. Shaw, R. Hachamovitch Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis J Am Coll Cardiol 39 2002 1151 1158
84. J.J. Bax, D. Poldermans, A. Elhendy Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography J Am Coll Cardiol 34 1999 163 169
85. C. Pedone, J.J. Bax, R.T. van Domburg Long-term prognostic value of ejection fraction changes during dobutamine-atropine stress echocardiography Coron Artery Dis 16 2005 309 313
86. R.J. Kim, E. Wu, A. Rafael The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction N Engl J Med 343 2000 1445 1453
87. J.B. Selvanayagam, A. Kardos, J.M. Francis Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization Circulation 110 2004 1535 1541
88. C. Jahnke, E. Nagel, R. Gebker Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging Circulation 115 2007 1769 1776
89. A. Wahl, I. Paetsch, A. Gollesch Safety and feasibility of high-dose dobutamine-atropine stress cardiovascular magnetic resonance for diagnosis of myocardial ischaemia: experience in 1000 consecutive cases Eur Heart J 25 2004 1230 1236
90. A. Wagner, H. Mahrholdt, T.A. Holly Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study Lancet 361 2003 374 379
91. S.D. Roes, T.A. Kaandorp, N.A. Marsan Agreement and disagreement between contrast-enhanced magnetic resonance imaging and nuclear imaging for assessment of myocardial viability Eur J Nucl Med Mol Imaging 36 2009 594 601
92. Y. Inaba, J.A. Chen, S.R. Bergmann Quantity of viable myocardium required to improve survival with revascularization in patients with ischemic cardiomyopathy: a meta-analysis J Nucl Cardiol 17 2010 646 654
93. R.S. Beanlands, T.D. Ruddy, R.A. deKemp Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function J Am Coll Cardiol 40 2002 1735 1743
94. R.S. Beanlands, G. Nichol, E. Huszti F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2) J Am Coll Cardiol 50 2007 2002 2012
95. R.H. Slart, J.J. Bax, J. de Boer Comparison of 99mTc-sestamibi/18FDG DISA SPECT with PET for the detection of viability in patients with coronary artery disease and left ventricular dysfunction Eur J Nucl Med Mol Imaging 32 2005 972 979
96. H.M. Siebelink, P.K. Blanksma, H.J. Crijns No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: a prospective, randomized comparison of patients with suspicion of jeopardized myocardium J Am Coll Cardiol 37 2001 81 88
97. D.D. Mendoza, S.B. Joshi, G. Weissman Viability imaging by cardiac computed tomography J Cardiovasc Comput Tomogr 4 2010 83 91
98. J.B. le Polain de Waroux, A.C. Pouleur, C. Goffinet Combined coronary and late-enhanced multidetector-computed tomography for delineation of the etiology of left ventricular dysfunction: comparison with coronary angiography and contrast-enhanced cardiac magnetic resonance imaging Eur Heart J 29 2008 2544 2551
99. M. Luu, W.G. Stevenson, L.W. Stevenson Diverse mechanisms of unexpected cardiac arrest in advanced heart failure Circulation 80 1989 1675 1680
100. J.L. Anderson, C.D. Adams, E.M. Antman 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 57 2011 e215 e367 10.1016/j.jacc.2011. 02.011
101. A.E. Epstein, J.P. DiMarco, K.A. Ellenbogen ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) J Am Coll Cardiol 51 2008 e1 e62
102. C.L. Grines, T.M. Bashore, H. Boudoulas Functional abnormalities in isolated left bundle branch block The effect of interventricular asynchrony Circulation 79 1989 845 853
103. A. Takeshita, L.L. Basta, J.M. Kioschos Effect of intermittent left bundle branch block on left ventricular performance Am J Med 56 1974 251 255
104. A.G. Fried, A.B. Parker, G.E. Newton Electrical and hemodynamic correlates of the maximal rate of pressure increase in the human left ventricle J Card Fail 5 1999 8 16
105. H.B. Xiao, C.H. Lee, D.G. Gibson Effect of left bundle branch block on diastolic function in dilated cardiomyopathy Br Heart J 66 1991 443 447
106. J.A. Erlebacher, S. Barbarash Intraventricular conduction delay and functional mitral regurgitation Am J Cardiol 88 2001 83 86 A7
107. M.E. Silverman, M.D. Pressel, J.C. Brackett Prognostic value of the signal-averaged electrocardiogram and a prolonged QRS in ischemic and nonischemic cardiomyopathy Am J Cardiol 75 1995 460 464
108. H.B. Xiao, C. Roy, S. Fujimoto Natural history of abnormal conduction and its relation to prognosis in patients with dilated cardiomyopathy Int J Cardiol 53 1996 163 170
109. W. Shamim, D.P. Francis, M. Yousufuddin Intraventricular conduction delay: a prognostic marker in chronic heart failure Int J Cardiol 70 1999 171 178
110. J.G. Cleland, J.C. Daubert, E. Erdmann The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 2005 1539 1549
111. M.R. Bristow, L.A. Saxon, J. Boehmer Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
112. D.J. Bradley, E.A. Bradley, K.L. Baughman Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials JAMA 289 2003 730 740
113. S.D. Solomon, E. Foster, M. Bourgoun Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy Circulation 122 2010 985 992
114. A.S. Tang, G.A. Wells, M. Talajic Cardiac-resynchronization therapy for mild-to-moderate heart failure N Engl J Med 363 2010 2385 2395
115. L.J. Gula, G.J. Klein, A.S. Hellkamp Ejection fraction assessment and survival: an analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Am Heart J 156 2008 1196 1200
116. W.T. Abraham, W.G. Fisher, A.L. Smith Cardiac resynchronization in chronic heart failure N Engl J Med 346 2002 1845 1853
117. J. Cleland, N. Freemantle, S. Ghio Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial J Am Coll Cardiol 52 2008 438 445
118. J.J. Bax, G.B. Bleeker, T.H. Marwick Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy J Am Coll Cardiol 44 2004 1834 1840
119. M. Penicka, J. Bartunek, B. De Bruyne Improvement of left ventricular function after cardiac resynchronization therapy is predicted by tissue Doppler imaging echocardiography Circulation 109 2004 978 983
120. E.S. Chung, A.R. Leon, L. Tavazzi Results of the Predictors of Response to CRT (PROSPECT) trial Circulation 117 2008 2608 2616
121. C. Ypenburg, R.J. Van Bommel, V. Delgado Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy J Am Coll Cardiol 52 2008 1402 1409
122. P. Sogaard, H. Egeblad, W.Y. Kim Tissue Doppler imaging predicts improved systolic performance and reversed left ventricular remodeling during long-term cardiac resynchronization therapy J Am Coll Cardiol 40 2002 723 730
123. C.M. Yu, J.W. Fung, Q. Zhang Tissue Doppler imaging is superior to strain rate imaging and postsystolic shortening on the prediction of reverse remodeling in both ischemic and nonischemic heart failure after cardiac resynchronization therapy Circulation 110 2004 66 73
124. J.F. Beshai, R.A. Grimm, S.F. Nagueh Cardiac-resynchronization therapy in heart failure with narrow QRS complexes N Engl J Med 357 2007 2461 2471
125. L. Parreira, J.F. Santos, J. Madeira Cardiac resynchronization therapy with sequential biventricular pacing: impact of echocardiography guided VV delay optimization on acute results Rev Port Cardiol 24 2005 1355 1365
126. N.S. Sawhney, A.D. Waggoner, S. Garhwal Randomized prospective trial of atrioventricular delay programming for cardiac resynchronization therapy Heart Rhythm 1 2004 562 567
127. R. Perry, C.G. De Pasquale, D.P. Chew QRS duration alone misses cardiac dyssynchrony in a substantial proportion of patients with chronic heart failure J Am Soc Echocardiogr 19 2006 1257 1263
128. C.M. Yu, H. Lin, Q. Zhang High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration Heart 89 2003 54 60
129. S.D. Roes, C.J. Borleffs, R.J. van der Geest Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter- defibrillator Circ Cardiovasc Imaging 2 2009 183 190
130. R.G. Assomull, S.K. Prasad, J. Lyne Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy J Am Coll Cardiol 48 2006 1977 1985
131. M. Yokokawa, H. Tada, K. Koyama Nontransmural scar detected by magnetic resonance imaging and origin of ventricular tachycardia in structural heart disease Pacing Clin Electrophysiol 32 Suppl 1 2009 S52 S56
132. K.C. Bilchick, V. Dimaano, K.C. Wu Cardiac magnetic resonance assessment of dyssynchrony and myocardial scar predicts function class improvement following cardiac resynchronization therapy J Am Coll Cardiol Img 1 2008 561 568
133. M.M. Boogers, S.D. Van Kriekinge, M.M. Henneman Quantitative gated SPECT-derived phase analysis on gated myocardial perfusion SPECT detects left ventricular dyssynchrony and predicts response to cardiac resynchronization therapy J Nucl Med 50 2009 718 725
134. M. Friehling, J. Chen, S. Saba A prospective pilot study to evaluate the relationship between acute change in left ventricular synchrony after cardiac resynchronization therapy and patient outcome using a single-injection gated SPECT protocol Circ Cardiovasc Imaging 4 2011 532 539
135. J. Chen, H. Nagaraj, P. Bhambhani Effect of alcohol septal ablation in patients with hypertrophic cardiomyopathy on left-ventricular mechanical dyssynchrony as assessed by phase analysis of gated SPECT myocardial perfusion imaging Int J Cardiovasc Imaging 28 2012 1375 1384
136. Deleted in proof.
137. M.A. Konstam, M.F. Rousseau, M.W. Kronenberg SOLVD Investigators Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure Circulation 86 1992 431 438
138. N.E. Doherty III, K.C. Seelos, J. Suzuki Application of cine nuclear magnetic resonance imaging for sequential evaluation of response to angiotensin-converting enzyme inhibitor therapy in dilated cardiomyopathy J Am Coll Cardiol 19 1992 1294 1302
139. S. Kasama, T. Toyama, H. Sumino Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction J Nucl Med 49 2008 907 914
140. F. Grothues, J.C. Moon, N.G. Bellenger Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance Am Heart J 147 2004 218 223
141. F. Grothues, G.C. Smith, J.C. Moon Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy Am J Cardiol 90 2002 29 34
142. J.H. McGowan, J.G. Cleland Reliability of reporting left ventricular systolic function by echocardiography: a systematic review of 3 methods Am Heart J 146 2003 388 397
143. C. Delagardelle, P. Feiereisen, M. Vaillant Reverse remodelling through exercise training is more pronounced in non-ischemic heart failure Clin Res Cardiol 97 2008 865 871
144. S. Borges-Neto, L.J. Shaw, K. Kesler Usefulness of serial radionuclide angiography in predicting cardiac death after coronary artery bypass grafting and comparison with clinical and cardiac catheterization data Am J Cardiol 79 1997 851 855